Photodynamic Therapy of Actinic Keratoses With Alacare®
NCT ID: NCT01571336
Last Updated: 2016-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
388 participants
OBSERVATIONAL
2012-04-30
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Study of Photodynamic Therapy vs. CO2 Laser Therapy in Treatment of Actinic Keratoses
NCT01481155
5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities
NCT03606122
Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis
NCT01656226
ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis
NCT05725213
Carac & PDT Combination in the Treatment Of Actinic Keratoses
NCT06712381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with 3 to 6 mild AK lesions on the hairless areas of the head and face which were treated with Alacare®-PDT according to the SPC
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
photonamic GmbH & Co. KG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Radny, MD
Role: STUDY_CHAIR
Dermatological group practice, Charlottenstraße 12, D-88045 Friedrichshafen, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medizinisches Zentrum Bonn Friedensplatz
Bonn, , Germany
Hautarztpraxis Prof. Kurzen
Freising, , Germany
Hautärztliche Gemeinschaftspraxis Dr. med. Peter Dworzak Dr. med. Peter Radny
Friedrichshafen, , Germany
Gemeinschaftspraxis Dres.Ina Röhrig-Petering und Holger Petering
Hildesheim, , Germany
Dermatologische Gemeinschaftspraxis Prof. Dr. J. Gille & Dr. K. Spieth-Gille
Königstein im Taunus, , Germany
ZENTderma
Mönchengladbach, , Germany
Facharzt für Haut- und Geschlechtskrankheiten
Radolfzell, , Germany
Praxis Prof. Dr. Thomas Dirschka
Wuppertal, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.